NASDAQ:SIEN - Sientra Stock Price, Price Target & More

$13.78 +0.52 (+3.92 %)
(As of 04/25/2018 08:36 AM ET)
Previous Close$13.26
Today's Range$12.99 - $13.83
52-Week Range$7.20 - $16.68
Volume457,300 shs
Average Volume337,195 shs
Market Capitalization$260.47 million
P/E RatioN/A
Dividend YieldN/A
Beta-1.06

About Sientra (NASDAQ:SIEN)

Sientra logoSientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. It also provides body contouring products; facial and nasal implants; saline-filled breast implant sizers to identify the correct style and size of implants; and non-breast tissue expanders for expanding tissue and skin surface area for burn care and other reconstructive use. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.

Receive SIEN News and Ratings via Email

Sign-up to receive the latest news and ratings for SIEN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:SIEN
CUSIPN/A
Phone805-562-3500

Debt

Debt-to-Equity RatioN/A
Current Ratio1.10%
Quick Ratio0.69%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$36.54 million
Price / Sales7.41
Cash FlowN/A
Price / CashN/A
Book Value$1.42 per share
Price / Book9.70

Profitability

EPS (Most Recent Fiscal Year)($2.82)
Net Income$-64,020,000.00
Net Margins-175.22%
Return on Equity-107.35%
Return on Assets-55.62%

Miscellaneous

Employees200
Outstanding Shares19,640,000

How to Become a New Pot Stock Millionaire

Sientra (NASDAQ:SIEN) Frequently Asked Questions

What is Sientra's stock symbol?

Sientra trades on the NASDAQ under the ticker symbol "SIEN."

How were Sientra's earnings last quarter?

Sientra (NASDAQ:SIEN) issued its earnings results on Tuesday, March, 13th. The medical instruments supplier reported ($0.92) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.71) by $0.21. The medical instruments supplier earned $11.10 million during the quarter, compared to analysts' expectations of $11.90 million. Sientra had a negative return on equity of 107.35% and a negative net margin of 175.22%. The firm's quarterly revenue was up 70.8% on a year-over-year basis. During the same period last year, the firm posted ($0.43) earnings per share. View Sientra's Earnings History.

What price target have analysts set for SIEN?

7 Wall Street analysts have issued 12-month price targets for Sientra's stock. Their predictions range from $12.00 to $18.00. On average, they anticipate Sientra's share price to reach $14.40 in the next year. View Analyst Ratings for Sientra.

What are Wall Street analysts saying about Sientra stock?

Here are some recent quotes from research analysts about Sientra stock:
  • 1. Canaccord Genuity analysts commented, "We reiterate our BUY rating on Sientra following PMA-S approval of the company’s new Vesta manufacturing facility. The timing of approval comes in line with our recent expectations for H1/18 and brings a close to what has been a two-and-a- half-year process to secure regulatory approval for a new manufacturing partner and remediate inventory constraints on the company’s Opus silicone breast implants. As a reminder, earlier in the Q1/18 Sientra obtained approval for 3 of the 4 required PMA-S filings required for the new facility (additional details here), and the most recent approval now allows them to manufacture and sell inventory out of their new Vesta manufacturing facility. While the final FDA approval came later than expected, we remind investors that Sientra has been manufacturing breast implants since early in the Q4/17 in anticipation of securing FDA approval in H1/18." (4/19/2018)
  • 2. According to Zacks Investment Research, "Sientra, Inc. is a medical aesthetics company. The Company offers plastic surgery implantable devices for cosmetic and reconstructive surgery, including Breast Implants, Tissue Expanders, Body Contouring, Implants and Specialty Products. Sentra's primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures. It also offers a range of other aesthetic and specialty products. Sientra, Inc. is headquartered in Santa Barbara, California. " (3/17/2018)

Who are some of Sientra's key competitors?

Who are Sientra's key executives?

Sientra's management team includes the folowing people:
  • Mr. Jeffrey M. Nugent, Chairman & CEO (Age 71)
  • Mr. Patrick F. Williams, CFO, Sr. VP, Principal Accounting Officer & Treasurer (Age 45)
  • Mr. Charles Huiner, Chief Operating Officer and Sr. VP of Corp. Devel. & Strategy (Age 47)
  • Ms. Deborah Bettencourt, VP of Customer Experience & Corp. Admin.
  • Mr. Jason O'Hearn, VP of Sales

Has Sientra been receiving favorable news coverage?

Headlines about SIEN stock have trended somewhat positive on Wednesday, according to Accern Sentiment Analysis. The research group identifies negative and positive media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Sientra earned a media sentiment score of 0.07 on Accern's scale. They also assigned news headlines about the medical instruments supplier an impact score of 44.89 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.

How do I buy shares of Sientra?

Shares of SIEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Sientra's stock price today?

One share of SIEN stock can currently be purchased for approximately $13.78.

How big of a company is Sientra?

Sientra has a market capitalization of $260.47 million and generates $36.54 million in revenue each year. The medical instruments supplier earns $-64,020,000.00 in net income (profit) each year or ($2.82) on an earnings per share basis. Sientra employs 200 workers across the globe.

How can I contact Sientra?

Sientra's mailing address is 420 SOUTH FAIRVIEW AVENUE SUITE 200, SANTA BARBARA CA, 93117. The medical instruments supplier can be reached via phone at 805-562-3500 or via email at [email protected]


MarketBeat Community Rating for Sientra (SIEN)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  112 (Vote Outperform)
Underperform Votes:  143 (Vote Underperform)
Total Votes:  255
MarketBeat's community ratings are surveys of what our community members think about Sientra and other stocks. Vote "Outperform" if you believe SIEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SIEN will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Sientra (NASDAQ:SIEN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
7 Wall Street analysts have issued ratings and price targets for Sientra in the last 12 months. Their average twelve-month price target is $14.40, suggesting that the stock has a possible upside of 4.50%. The high price target for SIEN is $18.00 and the low price target for SIEN is $12.00. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.862.833.002.80
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $14.40$14.00$15.00$13.75
Price Target Upside: 4.50% upside36.72% upside45.21% upside13.68% downside

Sientra (NASDAQ:SIEN) Consensus Price Target History

Price Target History for Sientra (NASDAQ:SIEN)

Sientra (NASDAQ:SIEN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/20/2018Leerink SwannReiterated RatingOutperformHighView Rating Details
4/19/2018Canaccord GenuityReiterated RatingBuy$18.00HighView Rating Details
4/19/2018Lake Street CapitalBoost Price TargetHold -> Hold$11.00 -> $13.00HighView Rating Details
3/22/2018Maxim GroupInitiated CoverageBuy -> Buy$15.00HighView Rating Details
3/1/2018William BlairReiterated RatingBuyLowView Rating Details
1/19/2018Stifel NicolausUpgradeHold -> Buy$14.00HighView Rating Details
7/11/2017StephensInitiated CoverageOverweight$12.00HighView Rating Details
(Data available from 4/25/2016 forward)

Earnings

Sientra (NASDAQ:SIEN) Earnings History and Estimates Chart

Earnings by Quarter for Sientra (NASDAQ:SIEN)

Sientra (NASDAQ:SIEN) Earnings Estimates

2018 EPS Consensus Estimate: ($2.71)
2019 EPS Consensus Estimate: ($1.98)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.89)($0.89)($0.89)
Q2 20182($0.71)($0.67)($0.69)
Q3 20181($0.60)($0.60)($0.60)
Q4 20181($0.53)($0.53)($0.53)
Q1 20192($0.63)($0.55)($0.59)
Q2 20192($0.51)($0.39)($0.45)
Q3 20192($0.60)($0.39)($0.50)
Q4 20192($0.51)($0.37)($0.44)

Sientra (NASDAQ SIEN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/13/2018Q4 2017($0.71)($0.92)$11.90 million$11.10 millionViewListenView Earnings Details
11/7/2017Q3 2017($0.6840)($0.7440)$10.54 million$9.80 millionViewN/AView Earnings Details
8/9/2017Q2 2017($0.59)($0.55)$6.97 million$8.20 millionViewListenView Earnings Details
5/9/2017Q1 2017($0.49)($0.61)$5.98 million$7.50 millionViewListenView Earnings Details
3/14/2017Q4 2016($0.52)($0.43)$6.76 million$6.50 millionViewN/AView Earnings Details
11/8/2016Q3 2016($0.55)($0.55)$5.60 million$6.53 millionViewN/AView Earnings Details
8/9/2016Q216($0.51)($0.56)$4.80 million$6.20 millionViewN/AView Earnings Details
5/5/2016Q1($0.74)($0.66)$2.40 million$1.47 millionViewN/AView Earnings Details
3/9/2016Q4($0.56)($1.57)$1.00 million$1.50 millionViewN/AView Earnings Details
11/16/2015Q3($0.33)($0.43)$9.93 millionViewListenView Earnings Details
8/12/2015Q215($0.33)($0.20)$13.84 million$14.20 millionViewListenView Earnings Details
5/13/2015Q115($0.40)($0.23)$11.50 million$12.40 millionViewListenView Earnings Details
3/11/2015Q414($0.35)($0.34)$10.70 million$12.12 millionViewListenView Earnings Details
11/20/2014Q314($6.94)$10.70 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Sientra (NASDAQ:SIEN) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Sientra (NASDAQ SIEN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 28.10%
Institutional Ownership Percentage: 77.38%
Insider Trading History for Sientra (NASDAQ:SIEN)
Institutional Ownership by Quarter for Sientra (NASDAQ:SIEN)

Sientra (NASDAQ SIEN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/12/2015Orbimed Advisors LlcMajor ShareholderSell287,891$5.98$1,721,588.18View SEC Filing  
10/9/2015Orbimed Advisors LlcMajor ShareholderSell666,609$7.18$4,786,252.62View SEC Filing  
10/6/2015Orbimed Advisors LlcMajor ShareholderSell193,000$8.71$1,681,030.00View SEC Filing  
10/1/2015Orbimed Advisors LlcMajor ShareholderSell101,898$10.24$1,043,435.52View SEC Filing  
9/28/2015Orbimed Advisors LlcMajor ShareholderSell150,908$10.58$1,596,606.64View SEC Filing  
10/29/2014Llp AbingworthMajor ShareholderBuy495,000$15.00$7,425,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Sientra (NASDAQ SIEN) News Headlines

Source:
DateHeadline
Research Analysts Offer Predictions for Sientras Q2 2018 Earnings (SIEN)Research Analysts Offer Predictions for Sientra's Q2 2018 Earnings (SIEN)
www.americanbankingnews.com - April 23 at 1:36 AM
Sientra (SIEN) Upgraded by BidaskClub to HoldSientra (SIEN) Upgraded by BidaskClub to Hold
www.americanbankingnews.com - April 22 at 7:06 AM
Sientra (SIEN) Upgraded by ValuEngine to BuySientra (SIEN) Upgraded by ValuEngine to Buy
www.americanbankingnews.com - April 21 at 8:42 AM
Sientra (SIEN) Given Outperform Rating at Leerink SwannSientra (SIEN) Given Outperform Rating at Leerink Swann
www.americanbankingnews.com - April 21 at 7:22 AM
Canaccord Genuity Reaffirms "Buy" Rating for Sientra (SIEN)Canaccord Genuity Reaffirms "Buy" Rating for Sientra (SIEN)
www.americanbankingnews.com - April 19 at 11:46 AM
Sientra (SIEN) Price Target Raised to $13.00Sientra (SIEN) Price Target Raised to $13.00
www.americanbankingnews.com - April 19 at 11:11 AM
10 Stocks To Watch For April 19, 201810 Stocks To Watch For April 19, 2018
www.benzinga.com - April 19 at 9:20 AM
BRIEF-Sientra Receives FDA Approval Of PMA SupplementBRIEF-Sientra Receives FDA Approval Of PMA Supplement
www.reuters.com - April 19 at 9:20 AM
US STOCKS ON THE MOVE-Taiwan Semiconductor, Apple, Amazon, Crown HoldingsUS STOCKS ON THE MOVE-Taiwan Semiconductor, Apple, Amazon, Crown Holdings
www.nasdaq.com - April 19 at 9:20 AM
Sientra Receives FDA Approval of PMA SupplementSientra Receives FDA Approval of PMA Supplement
finance.yahoo.com - April 18 at 4:49 PM
Sientra (SIEN) Earns "Buy" Rating from Lake Street CapitalSientra (SIEN) Earns "Buy" Rating from Lake Street Capital
www.americanbankingnews.com - April 14 at 10:43 AM
Lake Street Capital Reaffirms "Buy" Rating for Sientra (SIEN)Lake Street Capital Reaffirms "Buy" Rating for Sientra (SIEN)
www.americanbankingnews.com - April 12 at 5:09 PM
$11.00 Million in Sales Expected for Sientra (SIEN) This Quarter$11.00 Million in Sales Expected for Sientra (SIEN) This Quarter
www.americanbankingnews.com - April 12 at 1:47 AM
 Analysts Anticipate Sientra (SIEN) Will Post Earnings of -$0.90 Per Share Analysts Anticipate Sientra (SIEN) Will Post Earnings of -$0.90 Per Share
www.americanbankingnews.com - April 10 at 11:16 PM
Sientra Reports the Long-term Safety and Effectiveness of Silicone Gel Breast Implants with Results from the Largest ...Sientra Reports the Long-term Safety and Effectiveness of Silicone Gel Breast Implants with Results from the Largest ...
www.prnewswire.com - April 2 at 9:49 AM
Head-To-Head Comparison: Histogenics (HSGX) & Sientra (SIEN)Head-To-Head Comparison: Histogenics (HSGX) & Sientra (SIEN)
www.americanbankingnews.com - April 1 at 11:06 PM
Sientra Inc (SIEN) Receives Average Rating of "Hold" from BrokeragesSientra Inc (SIEN) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - April 1 at 8:16 AM
Sientra (SIEN) Upgraded to "Hold" at Zacks Investment ResearchSientra (SIEN) Upgraded to "Hold" at Zacks Investment Research
www.americanbankingnews.com - March 31 at 12:16 PM
Sientra (SIEN) Downgraded to "Sell" at BidaskClubSientra (SIEN) Downgraded to "Sell" at BidaskClub
www.americanbankingnews.com - March 30 at 2:18 PM
BRIEF-Sientra Says Reached An Agreement-In-Principle With Staff Of Division Of Enforcement Of US SECBRIEF-Sientra Says Reached An Agreement-In-Principle With Staff Of Division Of Enforcement Of US SEC
www.reuters.com - March 27 at 9:46 AM
Form 8-K Sientra, Inc. For: Mar 23Form 8-K Sientra, Inc. For: Mar 23
www.streetinsider.com - March 27 at 9:46 AM
Sientra Inc (SIEN) Expected to Post Quarterly Sales of $11.00 MillionSientra Inc (SIEN) Expected to Post Quarterly Sales of $11.00 Million
www.americanbankingnews.com - March 27 at 8:30 AM
Sientra (SIEN) Earns Buy Rating from Analysts at Maxim GroupSientra (SIEN) Earns Buy Rating from Analysts at Maxim Group
www.americanbankingnews.com - March 22 at 2:26 PM
Edited Transcript of SIEN earnings conference call or presentation 13-Mar-18 8:30pm GMTEdited Transcript of SIEN earnings conference call or presentation 13-Mar-18 8:30pm GMT
finance.yahoo.com - March 18 at 9:18 AM
Zacks Investment Research Upgrades Sientra (SIEN) to BuyZacks Investment Research Upgrades Sientra (SIEN) to Buy
www.americanbankingnews.com - March 17 at 2:48 PM
Sientra (SIEN) Upgraded to Hold by ValuEngineSientra (SIEN) Upgraded to Hold by ValuEngine
www.americanbankingnews.com - March 17 at 11:58 AM
Sientra (SIEN) Downgraded by Zacks Investment ResearchSientra (SIEN) Downgraded by Zacks Investment Research
www.americanbankingnews.com - March 17 at 11:16 AM
Analysts Offer Predictions for Sientra Incs Q1 2018 Earnings (SIEN)Analysts Offer Predictions for Sientra Inc's Q1 2018 Earnings (SIEN)
www.americanbankingnews.com - March 16 at 7:56 AM
Sientra (SIEN) Price Target Cut to $18.00 by Analysts at Canaccord GenuitySientra (SIEN) Price Target Cut to $18.00 by Analysts at Canaccord Genuity
www.americanbankingnews.com - March 14 at 11:12 AM
Sientra (SIEN) Posts Quarterly  Earnings Results, Misses Expectations By $0.21 EPSSientra (SIEN) Posts Quarterly Earnings Results, Misses Expectations By $0.21 EPS
www.americanbankingnews.com - March 14 at 9:48 AM
Sientra Reports Fourth Quarter and Full Year 2017 Financial ResultsSientra Reports Fourth Quarter and Full Year 2017 Financial Results
finance.yahoo.com - March 13 at 6:26 PM
ValuEngine Lowers Sientra (SIEN) to SellValuEngine Lowers Sientra (SIEN) to Sell
www.americanbankingnews.com - March 11 at 9:46 PM
Sientra Inc (SIEN) Receives Average Recommendation of "Hold" from BrokeragesSientra Inc (SIEN) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - March 7 at 11:45 AM
Investors Purchase Large Volume of Sientra Call Options (SIEN)Investors Purchase Large Volume of Sientra Call Options (SIEN)
www.americanbankingnews.com - March 6 at 8:24 AM
Senzar Asset Management LLC Boosts Holdings in Sientra Inc (SIEN)Senzar Asset Management LLC Boosts Holdings in Sientra Inc (SIEN)
www.americanbankingnews.com - March 5 at 3:44 PM
Short Interest in Sientra Inc (SIEN) Expands By 38.8%Short Interest in Sientra Inc (SIEN) Expands By 38.8%
www.americanbankingnews.com - March 4 at 1:40 AM
Sientra® to Release Fourth Quarter and Full Year 2017 Financial Results on Tuesday, March 13, 2017Sientra® to Release Fourth Quarter and Full Year 2017 Financial Results on Tuesday, March 13, 2017
finance.yahoo.com - March 2 at 5:11 PM
Sientra (SIEN) Receives "Buy" Rating from William BlairSientra (SIEN) Receives "Buy" Rating from William Blair
www.americanbankingnews.com - March 1 at 12:54 PM
X Square Capital LLC Takes $2.23 Million Position in Sientra Inc (SIEN)X Square Capital LLC Takes $2.23 Million Position in Sientra Inc (SIEN)
www.americanbankingnews.com - February 27 at 2:34 PM
Sientra (SIEN) Downgraded to "Sell" at ValuEngineSientra (SIEN) Downgraded to "Sell" at ValuEngine
www.americanbankingnews.com - February 25 at 6:35 PM
Sientra Launches New miraDry fresh™ Protocol for the miraDry® System at American Academy of Dermatology Annual MeetingSientra Launches New miraDry fresh™ Protocol for the miraDry® System at American Academy of Dermatology Annual Meeting
finance.yahoo.com - February 24 at 4:48 PM
Head to Head Contrast: Align Technology (ALGN) & Sientra (SIEN)Head to Head Contrast: Align Technology (ALGN) & Sientra (SIEN)
www.americanbankingnews.com - February 23 at 3:26 PM
The global tissue expanders market is anticipated to reach USD 1.5 billion by 2025The global tissue expanders market is anticipated to reach USD 1.5 billion by 2025
www.prnewswire.com - February 22 at 4:55 PM
Sientra (SIEN) Stock Rating Lowered by Lake Street CapitalSientra (SIEN) Stock Rating Lowered by Lake Street Capital
www.americanbankingnews.com - February 21 at 1:42 PM
BRIEF-Sientra Says Co Enters Into Agreement With Stifel, Nicolaus & Co IncBRIEF-Sientra Says Co Enters Into Agreement With Stifel, Nicolaus & Co Inc
www.reuters.com - February 21 at 9:24 AM
Sientra Inc (SIEN) Receives Average Rating of "Buy" from AnalystsSientra Inc (SIEN) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - February 10 at 7:50 AM
Sientra (SIEN) Upgraded to "Hold" at ValuEngineSientra (SIEN) Upgraded to "Hold" at ValuEngine
www.americanbankingnews.com - February 4 at 1:48 PM
FY2019 Earnings Forecast for Sientra Inc Issued By William Blair (SIEN)FY2019 Earnings Forecast for Sientra Inc Issued By William Blair (SIEN)
www.americanbankingnews.com - February 2 at 3:42 PM
Critical Analysis: Sientra (SIEN) vs. Neogen (NEOG)Critical Analysis: Sientra (SIEN) vs. Neogen (NEOG)
www.americanbankingnews.com - January 31 at 9:12 PM
BRIEF-Sientra Provides Update On FDA Review Of U.S. Manufacturing FacilityBRIEF-Sientra Provides Update On FDA Review Of U.S. Manufacturing Facility
www.reuters.com - January 31 at 9:31 AM

SEC Filings

Sientra (NASDAQ:SIEN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Sientra (NASDAQ:SIEN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Sientra (NASDAQ SIEN) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.